Cellular inhibitor of apoptosis‐2 is a critical regulator of apoptosis in airway epithelial cells treated with asthma‐related inflammatory cytokines

Aberrant apoptosis of airway epithelial cells ( AEC s) is a disease contributing feature in the airways of asthmatics. The proinflammatory cytokines tumor necrosis factor α ( TNF α) and interferon γ ( IFN γ) are increased in asthma and have been shown to contribute to apoptosis at the airways. In the present study, we investigated the role of the inhibitor of apoptosis protein ( IAP ) family in primary AEC s exposed to TNF α and IFN γ. IAP s are potent regulators of caspase activity elicited by the intrinsic and extrinsic apoptosis pathways. However, while caspase‐mediated apoptosis was observed in AEC s exposed to doxorubicin, it was not observed after cytokine treatment. Instead, AEC s exhibited proapoptotic changes evidenced by an increased Bax : Bcl2 transcript ratio and partial processing of procaspase‐3. Examination by quantitative reverse transcription polymerase chain reaction ( qRT ‐ PCR ) and W estern analysis showed that proapoptotic changes were associated with a time‐ and dose‐dependent induction of cellular IAP ‐2 ( cIAP2 ), potentiated primarily by IFN γ. The abundance of the IAP antagonists X‐linked IAP ‐associated factor 1 ( XAF 1) and second mitochondria‐derived activator of caspases did not change, although a moderate nuclear redistribution was observed for XAF1 , which was also observed for cIAP 2. Small interfering RNA ( siRNA )‐mediated depletion of cIAP2 from AEC s leads to caspase‐3 activation and poly ( ADP ‐ribose) polymerase cleavage, but this required extended cytokine exposure to produce a concomitant decrease in cIAP1 and Bcl2. These results indicate that AEC s possess endogenous mechanisms making them highly resistant to apoptosis due to asthma‐related inflammatory cytokines, and the activity of cIAP2 plays an important role in this protection.